| Benefits and harms of omalizumab treatment in adolescent and adult patients with chronic idiopathic (spontaneous) urticaria: a meta-analysis of “real-world” evidence MD Tharp, JA Bernstein, A Kavati, B Ortiz, K MacDonald, K Denhaerynck, ... JAMA dermatology 155 (1), 29-38, 2019 | 126 | 2019 |
| The national cost of asthma among school-aged children in the United States PW Sullivan, V Ghushchyan, P Navaratnam, HS Friedman, A Kavati, ... Annals of allergy, asthma & immunology 119 (3), 246-252. e1, 2017 | 115 | 2017 |
| Women manifest more severe COPD symptoms across the life course D DeMeo, R Sreeram, A Kavati, A Vegesna, H Meilan, A Yadao, T Wilcox, ... International Journal of COPD 2018 (13), 3021-3029, 2018 | 103 | 2018 |
| Effectiveness of omalizumab in adolescent and adult patients with chronic idiopathic/spontaneous urticaria: a systematic review of ‘real-world’evidence JA Bernstein, A Kavati, MD Tharp, B Ortiz, K MacDonald, K Denhaerynck, ... Expert opinion on biological therapy 18 (4), 425-448, 2018 | 89 | 2018 |
| Short-and long-term real-world effectiveness of omalizumab in severe allergic asthma: systematic review of 42 studies published 2008-2018 KM MacDonald, A Kavati, B Ortiz, A Alhossan, CS Lee, I Abraham Expert review of clinical immunology 15 (5), 553-569, 2019 | 88 | 2019 |
| Asthma control and disease burden in patients with asthma and allergic comorbidities LK Lee, E Obi, B Paknis, A Kavati, B Chipps Journal of Asthma 55 (2), 208-219, 2018 | 87 | 2018 |
| Efficacy and safety of omalizumab in children and adolescents with moderate-to-severe asthma: a systematic literature review J Corren, A Kavati, B Ortiz, JA Colby, K Ruiz, BA Maiese, SM Cadarette, ... Allergy and Asthma Proceedings 38 (4), 250-263, 2017 | 76 | 2017 |
| Contemporary treatment patterns and clinical outcomes of comorbid diabetes mellitus and HFrEF: the CHAMP-HF registry M Vaduganathan, GC Fonarow, SJ Greene, AD DeVore, A Kavati, ... Heart Failure 8 (6), 469-480, 2020 | 68 | 2020 |
| The national burden of poorly controlled asthma, school absence and parental work loss among school-aged children in the United States PW Sullivan, V Ghushchyan, P Navaratnam, HS Friedman, A Kavati, ... Journal of Asthma 55 (6), 659-667, 2018 | 66 | 2018 |
| School absence and productivity outcomes associated with childhood asthma in the USA P Sullivan, V Ghushchyan, P Navaratnam, H Friedman, A Kavati, B Ortiz, ... Journal of Asthma, 2017 | 66 | 2017 |
| National prevalence of poor asthma control and associated outcomes among school-aged children in the United States PW Sullivan, V Ghushchyan, P Navaratnam, HS Friedman, A Kavati, ... The Journal of Allergy and Clinical Immunology: In Practice 6 (2), 536-544. e1, 2018 | 48 | 2018 |
| Patient perceptions and familiarity with medical therapy for heart failure MD Samsky, L Lin, SJ Greene, SJ Lippmann, PN Peterson, ... JAMA cardiology 5 (3), 292-299, 2020 | 32 | 2020 |
| Health disparities among children with asthma in the United States by place of residence PW Sullivan, V Ghushchyan, A Kavati, P Navaratnam, HS Friedman, ... The Journal of Allergy and Clinical Immunology: In Practice 7 (1), 148-155, 2019 | 29 | 2019 |
| Comparative effectiveness of pegfilgrastim, filgrastim, and sargramostim prophylaxis for neutropenia-related hospitalization: two US retrospective claims analyses HJ Henk, L Becker, H Tan, J Yu, A Kavati, A Naeim, R Deeter, R Barron Journal of medical economics 16 (1), 160-168, 2013 | 29 | 2013 |
| Cost-effectiveness of omalizumab for the treatment of moderate-to-severe uncontrolled allergic asthma in the United States PW Sullivan, Q Li, SP Bilir, J Dang, A Kavati, M Yang, Y Rajput Current medical research and opinion 36 (1), 23-32, 2020 | 21 | 2020 |
| Trends in asthma control, treatment, health care utilization, and expenditures among children in the United States by place of residence: 2003-2014 PW Sullivan, V Ghushchyan, A Kavati, P Navaratnam, HS Friedman, ... The Journal of Allergy and Clinical Immunology: In Practice 7 (6), 1835-1842. e2, 2019 | 20 | 2019 |
| Asthma control, lung function, symptoms, and corticosteroid sparing after omalizumab initiation in patients with allergic asthma D Pilon, A Kavati, B Ortiz, B Paknis, A Vegesna, B Schiffman, M Zhdanava, ... Allergy and Asthma Proceedings 39 (2), 127-135, 2018 | 19 | 2018 |
| Real-world treatment patterns and outcomes of omalizumab use in patients with chronic idiopathic urticaria L Wang, X Ke, A Kavati, D Wertz, Q Huang, VJ Willey, JJ Stephenson, ... Current medical research and opinion 34 (1), 35-39, 2018 | 19 | 2018 |
| Exploring factors associated with health disparities in asthma and poorly controlled asthma among school-aged children in the US PW Sullivan, V Ghushchyan, P Navaratnam, HS Friedman, A Kavati, ... Journal of Asthma 57 (3), 271-285, 2020 | 17 | 2020 |
| Real-world use of omalizumab in patients with chronic idiopathic/spontaneous urticaria in the United States J Eghrari-Sabet, E Sher, A Kavati, D Pilon, M Zhdanava, MM Balp, ... Allergy and asthma proceedings 39 (3), 191-200, 2018 | 17 | 2018 |
